Enliven Therapeutics, Inc. (ELVN): 3 filed Feb 27, 2023

Form type

3

Filing date

Feb 27, 2023

Accession number

0001209191-23-013509

Filer

Enliven Therapeutics, Inc. (CIK 1672619)